iPierian ipierian.com

iPierian is a biotechnology company developing therapies for neurodegenerative disease, specifically focused on discovering monoclonal antibodies against targets of the Tau protein for treatment of Alzheimer's disease and other tauopathies (e.g. progressive supranuclear palsy, frontotemporal dementia). The company's lead antibody, IPN007, represents a new approach to Alzheimer's by targeting a novel form of secreted Tau protein that is differentially regulated in Alzheimer's disease patients, to...Show all

iPierian is a biotechnology company developing therapies for neurodegenerative disease, specifically focused on discovering monoclonal antibodies against targets of the Tau protein for treatment of Alzheimer's disease and other tauopathies (e.g. prog...Show all

See All Exits Recent Exits

Phone: 650-872-4700

Fax:

951 Gateway Boulevard

South San Francisco, 94080
California, United States

iPierian - Investments & Acquisitions

Show Real Data iPierian Investments